Abstract
Although essential in critical care medicine, mechanical ventilation often results in ventilator-induced lung injury. Low concentrations of hydrogen sulfide have been proven to have anti-inflammatory and anti-oxidative effects in the lung. The aim of this study was to analyze the kinetic effects of pre- and posttreatment with hydrogen sulfide in order to prevent lung injury as well as inflammatory and oxidative stress upon mechanical ventilation. Mice were either non-ventilated or mechanically ventilated with a tidal volume of 12 ml/kg for 6 h. Pretreated mice inhaled hydrogen sulfide in low dose for 1, 3, or 5 h prior to mechanical ventilation. Posttreated mice were ventilated with air followed by ventilation with hydrogen sulfide in various combinations. In addition, mice were ventilated with air for 10 h, or with air for 5 h and subsequently with hydrogen sulfide for 5 h. Histology, interleukin-1β, neutrophil counts, and reactive oxygen species formation were examined in the lungs. Both pre-and posttreatment with hydrogen sulfide time-dependently reduced or even prevented edema formation, gross histological damage, neutrophil influx and reactive oxygen species production in the lung. These results were also observed in posttreatment, when the experimental time was extended and hydrogen sulfide administration started as late as after 5 h air ventilation. In conclusion, hydrogen sulfide exerts lung protection even when its application is limited to a short or delayed period. The observed lung protection is mediated by inhibition of inflammatory and oxidative signaling.
Introduction
Despite advances in ventilator therapy over the last two decades [1], the risk that mechanical ventilation will induce or aggravate lung injury (i.e., ventilator-induced lung injury (VILI)) remains unacceptably high [2]. This is not only true for ventilated patients with pre-existing lung disease, but VILI also occurs during ventilation of healthy lungs [3,4]. VILI is characterized by lung tissue disruption, edema formation, excessive production of reactive oxygen species (ROS), and the development of an inflammatory response. Two mechanisms appear to play key roles within the process of VILI: first, constant cyclic stretching of the lungs can release pro-inflammatory cytokines such as interleukin-1β (IL-1β), and trigger the transmigration of neutrophil cells into the alveolar compartments [5,6]. Second, the excessive production of ROS upon mechanical ventilation may per se damage lung tissue by peroxidation of cell lipids, DNA breakage, or alteration of amino acids and cellular metabolism [7,8]. In order to limit both of these responses to mechanical ventilation and thus reduce lung injury, a treatment option targeted at these mechanisms would be highly desirable.
In this respect, hydrogen sulfide (H2S) is of emerging interest. Together with nitric oxide and carbon monoxide, H2S belongs to the family of so called endogenous gasotransmitters [9]. Given exogenously, its organ- and also lung-protective potential has been proven in various experimental models in the past [10–17]. We and others have previously shown that H2S inhalation prevents acute lung injury in a model of pulmonary inflammation [12], hyperoxic lung injury [13], ischemia-reperfusion injury [15], or ventilator-induced lung injury [10,11,16,17]. In these models, low concentrations of H2S limited inflammatory responses by preventing the release of pro-inflammatory cytokines and neutrophil accumulation in the lung. Moreover, oxidative stress was found to be clearly decreased in response to H2S application [13–15,17,18].
In earlier studies lung protection as well as anti-inflammatory or anti-oxidative effects were observed when H2S administration continued over the entire experimental course [10,11,16,17]. Up to now, only in ischemia-reperfusion models, pre- or postconditioning with H2S have been described, resulting in protection from cardiac (reviewed in [19]), retinal [20], intestinal [21–23], hepatic [24], or neuronal insults [25]. However, virtually nothing is known about time-dependent effects of H2S treatment in lung injury.
Here, we determined the time-dependent anti-inflammatory and anti-oxidative effects of inhaled H2S as pre- and posttreatment in a well-established mouse VILI-model. Our results provide evidence that H2S can protect mice from VILI by limiting inflammatory and oxidative responses when given prior to the onset of mechanical ventilation and also when the onset of H2S application is delayed during the course of injurious ventilation.
Materials and methods
Animals
Animal experiments were performed in accordance with the guidelines of the local animal care commission (University of Freiburg, Freiburg, Germany) and in conformance with the journals’ requirements for human and animal trials (ARRIVE guidelines). The study was approved by the local government, which had been advised by an ethics committee (Regierungspräsidium Freiburg, Freiburg, Germany, permission No. G-12/73). All surgery was performed under deep ketamine and acepromazine anesthesia, and all efforts were made to minimize suffering.
Experimental setup
Male C57BL/6N mice were obtained from Charles River Laboratories (Sulzfeld, Germany). Mice were anesthetized intraperitoneally (i.p., 90 mg/kg ketamine and 0.9 mg/kg acepromazine). As described earlier [26], an arterial line and a tracheal tube were inserted. In the case of mechanical ventilation, mice were connected to a rodent ventilator (Voltekenterprises, Toronto, ON, Canada), set as follows: tidal volume of 12 ml/kg, frequency of 80–90 breaths/minute, positive end-expiratory pressure of 2 cmH2O for 6 hours. Alveolar recruitment maneuvers were performed every 60 minutes (5 seconds of inspiratory pressure hold at 30 cmH2O). Directly after the onset of mechanical ventilation, muscular relaxation was induced by injection of pancuronium (2 mg/kg, i.p.) and maintained during the experiment by injection as needed. Likewise, general anesthesia was maintained by continuous i.p. administration of ketamine and acepromazine as needed. Peak pressure (Ppeak), plateau pressure (Pplateau), and mean arterial pressure (MAP) were monitored throughout the experiment; blood gas analyses were performed at the beginning (after 30 min of ventilation) and the end of the ventilation period (6 h). At the end of each experiment, mice were sacrificed by an overdosed injection of ketamine and acepromazine. Bronchoalveolar lavage (BAL) fluid was gained by flushing the right lung lobes. The lungs were preserved for histological examination as described previously [26].
The animal experiments were run in three independent experimental sets (Fig 1):
Set 1 Pretreatment (n = 7/group; 6 groups)
The control group spontaneously breathed air (control) for 6 hours. All other mice were either ventilated with synthetic air (6h air) or subjected to spontaneously breathe 80 parts per million (ppm) H2S for 1, 3, or 5 h prior to another 6 h ventilation with synthetic air (1 h H2S pre + 6 h air; 3 h H2S pre + 6 h air; 5 h H2S pre + 6 h air) or they were ventilated with synthetic air supplemented with 80 ppm H2S (6 h H2S; Fig 1A).
Set 2 Posttreatment (n = 7/group; 6 groups)
The control group spontaneously breathed air (control) for 6 hours. All other mice were either ventilated with synthetic air (6 h air) or they were first ventilated with synthetic air for 5, 3, or 1 h and then 80 ppm H2S was supplemented for another 1, 3, or 5 h (5 h air + 1 h H2S; 3 h air + 3 h H2S; 1 h air + 5 h H2S) or they were ventilated with synthetic air supplemented with 80 ppm H2S (6 h H2S; Fig 1B).
Set 3 expanded posttreatment (n = 6/group; 5 groups)
The control group spontaneously breathed air (control) for 6 hours. All other mice were either ventilated with synthetic air (6 h air), synthetic air supplemented with 80 ppm H2S (6 h H2S), or with synthetic air for 10 h (10 h air), or they were first ventilated with synthetic air for 5 h and then 80 ppm H2S was supplemented for another 5 h (5 h air + 5 h H2S; Fig 1C).
Histological analysis
Cryosections of the fixed left lung were stained with hematoxylin and eosin (H&E) and analyzed for alveolar wall thickness and VILI score as previously described [26].
Neutrophil and cytokine analysis
BAL fluid cells were separated and analyzed as described previously [11]. BAL supernatant was analyzed using an interleukin-1β (IL-1β) ELISA kit (R&D Systems GmbH, Wiesbaden, Germany) according to the manufacturers’ instructions.
Detection of reactive oxygen species (ROS)
Cryosections of unfixed frozen lung tissue samples were stained with dihydroethidium (Life Technologies GmbH, Darmstadt, Germany) and analyzed as described previously in order to detect ROS [13,17,26].
Statistical analysis
All animal experiments were performed with n = 7 (Set 1 and 2) or n = 6 (Set 3) mice per group as indicated. Power calculations were performed prior to the study in order to define group sizes. Graphs represent means ± standard error of means (SEM) and were created with SigmaPlot 11.0 (Systat Software Inc., Erkrath, Germany). Data were further analyzed for normal variation prior to one way analysis of variance (ANOVA) followed by the Tukey`s post hoc test. P<0.05 was considered significant. All calculations were performed with GraphPad Prism 5 (GraphPad Software, Inc., La Jolla, CA USA).
Results
Effect of H2S pretreatment on physiological parameters
Blood gas analysis for PaO2, PaCO2, and pH at the end of the ventilation period did not differ between 6 h air, 6 h H2S ventilated, or 1, 3, 5 h H2S pretreated groups, followed by additional 6 h air ventilation (S1 Table). With respect to circulatory function, only after 5 h of H2S preconditioning followed by 6 h air ventilation, mean arterial pressure was reduced compared to 6 h air ventilation alone, while mean arterial pressure (MAP) in all other groups did not vary. Peak pressure, plateau pressure, and static compliance did not differ between groups (S1 Table).
Effect of H2S pretreatment on ventilator-induced lung injury
Compared to non-ventilated controls, mechanical ventilation with air for 6 h caused alveolar wall thickening, i.e., edema formation (Fig 2A). Pretreatment with inhalative H2S for 1 h prior to mechanical ventilation only marginally reduced alveolar wall thickening, while pretreatment with H2S for 3 or 5 h diminished alveolar wall thickening back to control levels (Fig 2A). Likewise, 6 h ventilation with H2S completely prevented the development of alveolar wall thickening, which was also confirmed by quantitative analysis (Fig 2B). Similar results were obtained by calculating an overall VILI score (Fig 2C). While mechanical ventilation with air alone led to a significantly augmented VILI score compared to controls and all other treatments, there was a stepwise reduction from 1 and 3 h H2S pretreatment to 5 h H2S pretreatment and 6 h H2S ventilation. The VILI scores of the latter two groups were comparable to control levels (Fig 2C).
Effect of H2S pretreatment on lung inflammation and oxidative stress
With respect to lung inflammatory parameters, we observed a slight increase in the release of the pro-inflammatory cytokine IL-1β following 6 h air ventilation and in all H2S pretreated groups compared to controls. In the 6 h H2S ventilation group, cytokine counts tended to be lower (Fig 3A). Mechanical ventilation with air induced a vast influx of neutrophils into the bronchoalveolar space compared to controls and all other groups (Fig 3B). Pretreatment with H2S for 1, 3, or 5 h reduced neutrophil sequestration, while 6 h ventilation with H2S alone nearly prevented neutrophil accumulation (Fig 3B). Compared to controls, air ventilation for 6 h increased ROS production which was reduced by H2S pretreatment and 6 h H2S ventilation (Fig 3C and 3D).
Effect of H2S posttreatment on physiological parameters
Compared to 6 h air ventilation, 3 h air + 3 h H2S ventilation or 6 h H2S ventilation alone resulted in reduced PaO2 levels at the end of the experiment (S2 Table). PaCO2 did not differ between groups. pH was only decreased in the 3 h air + 3 h H2S and in the 1 h air + 5 h H2S groups compared to 6 h air ventilation. MAP was reduced in the 3 h air + 3 h H2S and in the 6 h H2S groups compared to 6 h air ventilation and in the case of 6 h H2S treatment also in comparison to the 5 h air + 1 h H2S group. Peak and plateau pressure as well as static compliance did not differ between groups (S2 Table).
Effect of H2S posttreatment on ventilator-induced lung injury
Compared to non-ventilated controls, alveolar wall thickness was substantially increased after 6 h air ventilation. Ventilation with H2S for 1, 3, or 5 h after 5, 3, or 1 h air ventilation significantly decreased and 6 h H2S ventilation completely prevented alveolar wall thickening (Fig 4Aand 4B). Likewise, there was an increase of the overall VILI score after 6 h air ventilation compared to controls that was reduced by postponed treatment with H2S or even prevented by 6 h H2S ventilation (Fig 4C).
Effect of H2S posttreatment on lung inflammation and oxidative stress
IL-1β release was induced in all air ventilation groups, irrespective of additional delayed H2S treatment compared to non-ventilated controls, while there was a slight reduction in cytokine readings after 6 h of H2S ventilation alone (Fig 5A). Neutrophil sequestration was clearly induced by 6 h air ventilation compared to controls. H2S ventilation for 1 h after 5 h air ventilation tended to decrease neutrophil accumulation, but did not show statistical significance. When H2S inhalation began after 3 or 1 h, or simultaneously with mechanical ventilation, neutrophil influx into the alveolar space was substantially inhibited (Fig 5B).
Compared to controls, formation of reactive oxygen species was augmented in lung tissue after 6 h air ventilation. 5 h air ventilation followed by another 1 h of H2S ventilation slightly reduced ROS levels, while 3 h air vent + 3 h H2S vent again increased ROS production. 1 h air ventilation followed by 5 h H2S ventilation or 6 h H2S ventilation completely abolished ROS production, thus ROS detection was comparable to controls (Fig 5C to 5D).
Effect of expanded H2S posttreatment on physiological parameters
In order to answer the question of whether or not the above observed effects of H2S posttreatment would be limited to a total experimental time of 6h, two groups were ventilated over 10 h with one group starting H2S after 5 h of air ventilation. Compared to 6 h air ventilation, 6 h H2S ventilation lowered PaO2 levels (S3 Table), PaCO2 were indifferent between groups. pH was reduced in both 10 h air and 5 h air + 5 h H2S groups with respect to 6 h air ventilation. Mean arterial pressure, peak and plateau pressure, and static compliance were not different between groups (S3 Table).
Effect of expanded H2S posttreatment on ventilator-induced lung injury
Mechanical ventilation for 6 or 10 h with air increased alveolar wall thickness compared to non-ventilated controls which was abolished by 6 h H2S and 5 h air ventilation followed by another 5 h of H2S ventilation (Fig 6A and 6B). The calculation of an overall VILI score resulted in significantly elevated scores for the 6 and 10 h air ventilation group compared to all other groups (Fig 6C).
Effect of expanded H2S posttreatment on lung inflammation and oxidative stress
Compared to non-ventilated controls, 6 h air ventilation led to a slight increase in IL-1β release, that was again reduced by 6 h H2S. Both 10 h air ventilation and 5 h air followed by 5 h H2S ventilation further increased IL-1β cytokine levels (Fig 7A). Likewise, neutrophil influx into the bronchoalveolar space was induced by 6h air ventilation compared to non-ventilated controls. 6 h H2S ventilation reduced neutrophil sequestration back to control levels. 10 h air ventilation again led to increased neutrophil numbers in the BAL, and the same finding was made when mice received 5 h air ventilation followed by another 5 h of H2S ventilation (Fig 7B).
Formation of reactive oxygen species were elevated after 6 h air ventilation compared to non-ventilated controls. 6 h H2S ventilation inhibited ROS production. Again, there was a further increase in ROS after 10 h air ventilation as compared to 6 h ventilation and a reduction in ROS levels was observed when mice were ventilated for 5 h with air, followed by 5 h H2S ventilation (Fig 7C). These findings were confirmed by densitometric analysis of ROS fluorescence intensity for all groups (Fig 7D).
Discussion
We have previously shown that inhalation of 80 ppm H2S prevents VILI when given during the entire course of mechanical ventilation [11,16,17]. In contrast to higher H2S concentrations, no acute or chronic effects were observed by us and others in mice with 80 ppm H2S [11,27,28], while lower concentrations failed to mediate lung protection in VILI [14]. However, nothing is known so far about the time-dependent effects of H2S treatment in VILI. To answer the question whether pre- or posttreatment as well as shorter application times of H2S would have similar effects on VILI, inflammation and oxidative stress, we extensively examined the effects of H2S pre- and posttreatment on lung injury, inflammation and oxidation.
H2S pretreatment
Our results suggest that inhalative H2S pretreatment protects the lung against VILI. This finding is of increasing interest, since it may support existing or even reveal novel strategies, aiming to diminish forthcoming ventilator-induced lung injury. In the current study, this notion is supported by the observed substantial reduction in edema formation and VILI score compared to non-pretreated mice. These findings are in line with results from animal models of myocardial infarct injury [29] and hepatic [24], cardiac [30], cerebral [25], or retinal ischemia-reperfusion injury [20]. Here, H2S preconditioning clearly prevented organ injury. Our results further suggest that the longer H2S is applied prior to the onset of ventilation, the more protection is achieved. This observation appears interesting, because gaseous H2S is rapidly eliminated and extending the time of H2S inhalation should not result in accumulation of the molecule in mammalian cells [9]. A possible explanation for the observed time-dependency could be seen in differential gene expression patterns upon H2S application, in that upregulation or suppression of H2S sensitive genes might count for increased lung protection. This notion is supported by our previously published data on H2S mediated gene expression [16] and by a recent study by Roberts et al. [31]. In the latter report, rats inhaled 200 ppm H2S for 3 h per day on up to 5 consecutive days and gene expression patterns in the nasal respiratory epithelium shifted over time from genes involved in inflammation and anti-oxidation to genes associated with matrix remodeling.
It is well known that cyclic stretching of the lung leads to an inflammatory response [5,6]. We have previously shown that H2S inhalation inhibits pro-inflammatory cytokine release and neutrophil transmigration during mechanical ventilation [11,17]. Likewise, in the current study we observed increased IL-1β and neutrophils in the BAL which were decreased in the presence of 6 h H2S inhalation. Thus, continuous H2S application appears to inhibit the inflammatory response upon mechanical ventilation. Interestingly, H2S pretreatment did not affect IL-1β release. These findings are in contrast to previously reported data. In a cerebral ischemia-reperfusion injury model, pretreatment with 40 ppm H2S for 8 h each day for 7 days reduced IL-6 and TNF-α cytokine release [25]. Similar results were found in a rat model of small intestine ischemia-reperfusion injury [21]. There, rats were treated with the soluble H2S donor sodium hydrosulfide 24 h prior to ischemia-reperfusion and TNF-α release was diminished [21]. In the light of these findings, we suppose that IL-1β might either not be directly involved in the protective effects observed, or measuring IL-1β at the end of the experiment was too late to detect important mechanistic differences between groups. Another key step in the development of VILI and inflammation is reflected by neutrophil transmigration into the bronchoalveolar space [5]. With respect to H2S preconditioning, neutrophil numbers have not been examined in other studies. However, in models of small intestine ischemia-reperfusion injury, sodium hydrosulfide application 24 h prior to ischemia-reperfusion clearly inhibited leukocyte rolling and adhesion [22,23]. In the current study, H2S pretreatment clearly reduced neutrophil infiltration, irrespective of the duration of pretreatment, strongly suggesting that H2S inhalation prior to the onset of ventilation is sufficient to inhibit inflammatory responses during mechanical ventilation.
The excessive production of ROS due to cyclic stretching is clearly involved in the exacerbation of inflammation and VILI [7]. Here we demonstrate that H2S pretreatment prevents the increase of ROS formation. Recent findings from our lab point in the same direction: H2S treatment inhibited excessive ROS production in both ventilator- [17] and hyperoxia-induced lung injury [13] which was associated with lung protection. These findings underline the highly anti-oxidative capability of exogenous H2S in vivo. A few previously published studies using other models, other species and in vitro experiments underscore our results. For instance, Ji et al. observed in a rat model of cerebral ischemia-reperfusion injury that malondialdehyd and 8-hydroxy-2'-deoxyguanosine readings, as markers for oxidative stress, were reduced due to H2S inhalation for 8 h per day on 7 days prior to ischemia-reperfusion [25]. Incubation of neuronal cells [32–34], H9c2 cardiomyoblasts [35,36], or kidney epithelial cells [37] with H2S prior to injurious treatment resulted in a marked decrease of ROS production, which was accompanied by cell protection. Here, we extended our recent findings and show for the first time even that H2S preconditioning is sufficient to reduce ROS formation in VILI, suggesting that this step might also be involved in reducing the inflammatory response and mediating lung protection.
H2S Posttreatment
In order to answer the question whether or not H2S has the potential to limit lung injury when given after the insult has been set, animals were posttreated with H2S after the onset of mechanical ventilation. In the present study, we were able to demonstrate that even postponing H2S application reduces lung injury in a time-dependent fashion, underlining the effective and therapeutic potential of H2S. In a long term model of myocardial infarction, application of 3 boluses of sodium hydrosulfide on 3 consecutive days after the initial trauma was also sufficient to reduce infarct size [29]. However, our findings are in contrast to a more recent study that revealed no improvement of histological signs of lung injury when soluble sulfide was administered continuously, starting directly after induction of blunt chest trauma [38]. To the best of our knowledge, no data exist for the effect of H2S posttreatment in VILI. In the present study, we clearly show that H2S posttreatment protects against VILI.
It is likely that regulation of the inflammatory response has a significant role in the orchestration of posttreatment organ protection by H2S [9]. However, and as is our observation in H2S pretreatment, H2S showed only a reducing effect on IL-1β release when given with the onset of ventilation and continued over the entire ventilation period. Postponing H2S administration did not affect the cytokine release in our model. The above mentioned study on posttreatment in blunt chest trauma demonstrated similarly inconsistent results for lung cytokine release. In plasma, IL-6 was unaffected by H2S, while the anti-inflammatory cytokine IL-10 was clearly elevated, suggesting at least a systemic anti-inflammatory role for H2S posttreatment in lung trauma [38]. In our study, neutrophil transmigration into the alveolar space was diminished by H2S posttreatment. The longer and earlier H2S was applied for, the more pronounced was the effect. Because neutrophils were found to start transmigration into the bronchoalveolar space as early as 4 h after the onset of mechanical ventilation in our model, it is not surprising that H2S posttreatment failed to completely prevent neutrophil sequestration when given in the final hour of ventilation. The marked decrease in neutrophil numbers compared to ventilation alone may be explained by a direct impact of H2S on leukocyte transmigration capacity, as described for H2S pretreatment [23,39].
As discussed above, the oxidative responses are strongly associated with inflammation and the development of lung injury upon mechanical ventilation. The role of H2S posttreatment in regulating excessive ROS production remains unclear. In a rat model of lung injury induced by blast limb trauma, oxidative stress was characterized by malondialdehyd content and superoxide dismutase activity. Here, H2S posttreatment reduced oxidative stress as well as lung injury [40]. Our data point in the same direction and clearly show that even postponed H2S treatment is able to inhibit ROS production and oxidative stress. Somewhat surprising is the observation that starting H2S application in the middle of the ventilation period, i.e., at 3 h, did not limit ROS production in a linear time-response function. The reason for this result may be based on experimental variability but remains speculative. Nonetheless, in our setting 1 h of treatment at the end of ventilation was sufficient to reduce ROS formation, underlining the potential of H2S to interfere with the production of free radicals. One possible mechanism may be H2S-induced upregulation of Akt phosphorylation [17].
Taking the above discussed results into account, we finally hypothesized that (1) H2S might even affect VILI when applied at a time point at which lung injury has already been fully established and (2) this effect would be even more pronounced, if H2S were to be continuously given for several hours. Therefore, we prolonged the total ventilation time in a third set of experiments to 10 h and began to apply H2S as late as after 5 h. The data show clearly that even postponing H2S inhalation for 5 h during injurious ventilation finally leads to substantial protection against lung damage. Most interestingly, the observed protection appears independent of the anti-inflammatory effects of H2S, because neither cytokine release nor neutrophil accumulation was affected by H2S as compared to ventilation alone. However, ROS formation was completely prevented supporting the hypothesis that oxidative stress is the key mediator in VILI and that the anti-oxidative action of H2S represents the major protective mechanism.
Conclusions
The study examines the protective effects of inhaled H2S in VILI in both a pre- as well as posttreatment setting. We show for the first time that pretreatment with H2S time-dependently prevents lung damage by inhibiting inflammation and ROS formation. The same is true when H2S administration starts after the onset of injury, even when given at a time point when lung injury has already occurred. The inhibition of oxidative stress by H2S appears to account for H2S mediated lung protection. Taken together, H2S pre- or posttreatment displayed therapeutic potential against lung injury under experimental conditions.
Supporting information
Acknowledgments
The authors thank E. Bodurova (Life Imaging Centre, Albert-Ludwigs-University Freiburg, Germany) for excellent technical assistance.
The authors received no specific funding for this work.
Data Availability
All relevant data are within the paper and its Supporting Information files.
Funding Statement
The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing.
References
- 1.Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000; 342: 1301–1308. doi: 10.1056/NEJM200005043421801 [DOI] [PubMed] [Google Scholar]
- 2.Belperio JA, Keane MP, Lynch JP III, Strieter RM The role of cytokines during the pathogenesis of ventilator-associated and ventilator-induced lung injury. Semin Respir Crit Care Med. 2006; 27: 350–364. doi: 10.1055/s-2006-948289 [DOI] [PubMed] [Google Scholar]
- 3.Neto AS, Simonis FD, Barbas CS, Biehl M, Determann RM, Elmer J, et al. Lung-Protective Ventilation With Low Tidal Volumes and the Occurrence of Pulmonary Complications in Patients Without Acute Respiratory Distress Syndrome: A Systematic Review and Individual Patient Data Analysis. Crit Care Med. 2015; 43: 2155–2163. doi: 10.1097/CCM.0000000000001189 [DOI] [PubMed] [Google Scholar]
- 4.Serpa NA, Hemmes SN, Barbas CS, Beiderlinden M, Biehl M, Binnekade JM, et al. Protective versus Conventional Ventilation for Surgery: A Systematic Review and Individual Patient Data Meta-analysis. Anesthesiology. 2015; 123: 66–78. doi: 10.1097/ALN.0000000000000706 [DOI] [PubMed] [Google Scholar]
- 5.Lionetti V, Recchia FA, Ranieri VM Overview of ventilator-induced lung injury mechanisms. Curr Opin Crit Care. 2005; 11: 82–86. [DOI] [PubMed] [Google Scholar]
- 6.Ricard JD, Dreyfuss D, Saumon G Production of inflammatory cytokines in ventilator-induced lung injury: a reappraisal. Am J Respir Crit Care Med. 2001; 163: 1176–1180. doi: 10.1164/ajrccm.163.5.2006053 [DOI] [PubMed] [Google Scholar]
- 7.Chapman KE, Sinclair SE, Zhuang D, Hassid A, Desai LP, Waters CM Cyclic mechanical strain increases reactive oxygen species production in pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2005; 289: L834–L841. doi: 10.1152/ajplung.00069.2005 [DOI] [PubMed] [Google Scholar]
- 8.Wright DT, Cohn LA, Li H, Fischer B, Li CM, Adler KB Interactions of oxygen radicals with airway epithelium. Environ Health Perspect. 1994; 102 Suppl 10: 85–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Szabo C Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov. 2007; 6: 917–935. doi: 10.1038/nrd2425 [DOI] [PubMed] [Google Scholar]
- 10.Aslami H, Heinen A, Roelofs JJ, Zuurbier CJ, Schultz MJ, Juffermans NP Suspended animation inducer hydrogen sulfide is protective in an in vivo model of ventilator-induced lung injury. Intensive Care Med. 2010; 36: 1946–1952. doi: 10.1007/s00134-010-2022-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Faller S, Ryter SW, Choi AM, Loop T, Schmidt R, Hoetzel A Inhaled hydrogen sulfide protects against ventilator-induced lung injury. Anesthesiology. 2010; 113: 104–115. doi: 10.1097/ALN.0b013e3181de7107 [DOI] [PubMed] [Google Scholar]
- 12.Faller S, Zimmermann KK, Strosing KM, Engelstaedter H, Buerkle H, Schmidt R, et al. Inhaled hydrogen sulfide protects against lipopolysaccharide-induced acute lung injury in mice. Med Gas Res. 2012; 2: 26 doi: 10.1186/2045-9912-2-26 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Faller S, Spassov SG, Zimmermann KK, Ryter SW, Buerkle H, Loop T, et al. Hydrogen sulfide prevents hyperoxia-induced lung injury by downregulating reactive oxygen species formation and angiopoietin-2 release. Curr Pharm Des. 2013; 19: 2715–2721. [DOI] [PubMed] [Google Scholar]
- 14.Francis RC, Vaporidi K, Bloch KD, Ichinose F, Zapol WM Protective and Detrimental Effects of Sodium Sulfide and Hydrogen Sulfide in Murine Ventilator-induced Lung Injury. Anesthesiology. 2011; 115: 1012–1021. doi: 10.1097/ALN.0b013e31823306cf [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Fu Z, Liu X, Geng B, Fang L, Tang C Hydrogen sulfide protects rat lung from ischemia-reperfusion injury. Life Sci. 2008; 82: 1196–1202. doi: 10.1016/j.lfs.2008.04.005 [DOI] [PubMed] [Google Scholar]
- 16.Spassov S, Pfeifer D, Strosing K, Ryter S, Hummel M, Faller S, et al. Genetic targets of hydrogen sulfide in ventilator-induced lung injury—a microarray study. PLoS One. 2014; 9: e102401 doi: 10.1371/journal.pone.0102401 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Spassov SG, Donus R, Ihle PM, Engelstaedter H, Hoetzel A, Faller S Hydrogen Sulfide Prevents Formation of Reactive Oxygen Species through PI3K/Akt Signaling and Limits Ventilator-Induced Lung Injury. Oxid Med Cell Longev. 2017; 2017: 3715037 doi: 10.1155/2017/3715037 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Li HD, Zhang ZR, Zhang QX, Qin ZC, He DM, Chen JS Treatment with exogenous hydrogen sulfide attenuates hyperoxia-induced acute lung injury in mice. Eur J Appl Physiol. 2013; 113: 1555–1563. doi: 10.1007/s00421-012-2584-5 [DOI] [PubMed] [Google Scholar]
- 19.Andreadou I, Iliodromitis EK, Rassaf T, Schulz R, Papapetropoulos A, Ferdinandy P The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning. Br J Pharmacol. 2015; 172: 1587–1606. doi: 10.1111/bph.12811 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Biermann J, Lagreze WA, Schallner N, Schwer CI, Goebel U Inhalative preconditioning with hydrogen sulfide attenuated apoptosis after retinal ischemia/reperfusion injury. Mol Vis. 2011; 17: 1275–1286. [PMC free article] [PubMed] [Google Scholar]
- 21.Liu Y, Kalogeris T, Wang M, Zuidema MY, Wang Q, Dai H, et al. Hydrogen sulfide preconditioning or neutrophil depletion attenuates ischemia-reperfusion-induced mitochondrial dysfunction in rat small intestine. Am J Physiol Gastrointest Liver Physiol. 2012; 302: G44–G54. doi: 10.1152/ajpgi.00413.2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Yusof M, Kamada K, Kalogeris T, Gaskin FS, Korthuis RJ Hydrogen sulfide triggers late-phase preconditioning in postischemic small intestine by an NO- and p38 MAPK-dependent mechanism. Am J Physiol Heart Circ Physiol. 2009; 296: H868–H876. doi: 10.1152/ajpheart.01111.2007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Zuidema MY, Peyton KJ, Fay WP, Durante W, Korthuis RJ Antecedent hydrogen sulfide elicits an anti-inflammatory phenotype in postischemic murine small intestine: role of heme oxygenase-1. Am J Physiol Heart Circ Physiol. 2011; 301: H888–H894. doi: 10.1152/ajpheart.00432.2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Zhang Q, Fu H, Zhang H, Xu F, Zou Z, Liu M, et al. Hydrogen sulfide preconditioning protects rat liver against ischemia/reperfusion injury by activating Akt-GSK-3beta signaling and inhibiting mitochondrial permeability transition. PLoS One. 2013; 8: e74422 doi: 10.1371/journal.pone.0074422 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Ji K, Xue L, Cheng J, Bai Y Preconditioning of H2S inhalation protects against cerebral ischemia/reperfusion injury by induction of HSP70 through PI3K/Akt/Nrf2 pathway. Brain Res Bull. 2016; 121: 68–74. doi: 10.1016/j.brainresbull.2015.12.007 [DOI] [PubMed] [Google Scholar]
- 26.Strosing KM, Faller S, Gyllenram V, Engelstaedter H, Buerkle H, Spassov S, et al. Inhaled Anesthetics Exert Different Protective Properties in a Mouse Model of Ventilator-Induced Lung Injury. Anesth Analg. 2016. [DOI] [PubMed] [Google Scholar]
- 27.Blackstone E, Morrison M, Roth MB H2S induces a suspended animation-like state in mice. Science. 2005; 308: 518 doi: 10.1126/science.1108581 [DOI] [PubMed] [Google Scholar]
- 28.Beauchamp RO Jr., Bus JS, Popp JA, Boreiko CJ, Andjelkovich DA A critical review of the literature on hydrogen sulfide toxicity. Crit Rev Toxicol. 1984; 13: 25–97. doi: 10.3109/10408448409029321 [DOI] [PubMed] [Google Scholar]
- 29.Pan TT, Chen YQ, Bian JS All in the timing: a comparison between the cardioprotection induced by H2S preconditioning and post-infarction treatment. Eur J Pharmacol. 2009; 616: 160–165. doi: 10.1016/j.ejphar.2009.05.023 [DOI] [PubMed] [Google Scholar]
- 30.Li C, Hu M, Wang Y, Lu H, Deng J, Yan X Hydrogen sulfide preconditioning protects against myocardial ischemia/reperfusion injury in rats through inhibition of endo/sarcoplasmic reticulum stress. Int J Clin Exp Pathol. 2015; 8: 7740–7751. [PMC free article] [PubMed] [Google Scholar]
- 31.Roberts ES, Thomas RS, Dorman DC Gene expression changes following acute hydrogen sulfide (H2S)-induced nasal respiratory epithelial injury. Toxicol Pathol. 2008; 36: 560–567. doi: 10.1177/0192623308317422 [DOI] [PubMed] [Google Scholar]
- 32.Lan A, Xu W, Zhang H, Hua X, Zheng D, Guo R, et al. Inhibition of ROS-activated p38MAPK pathway is involved in the protective effect of H2S against chemical hypoxia-induced inflammation in PC12 cells. Neurochem Res. 2013; 38: 1454–1466. doi: 10.1007/s11064-013-1044-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Liu YY, Nagpure BV, Wong PT, Bian JS Hydrogen sulfide protects SH-SY5Y neuronal cells against d-galactose induced cell injury by suppression of advanced glycation end products formation and oxidative stress. Neurochem Int. 2013; 62: 603–609. doi: 10.1016/j.neuint.2012.12.010 [DOI] [PubMed] [Google Scholar]
- 34.Luo Y, Yang X, Zhao S, Wei C, Yin Y, Liu T, et al. Hydrogen sulfide prevents OGD/R-induced apoptosis via improving mitochondrial dysfunction and suppressing an ROS-mediated caspase-3 pathway in cortical neurons. Neurochem Int. 2013; 63: 826–831. doi: 10.1016/j.neuint.2013.06.004 [DOI] [PubMed] [Google Scholar]
- 35.Guo R, Wu K, Chen J, Mo L, Hua X, Zheng D, et al. Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK/NFkappaB pathway in H9c2 cardiac cells. Cell Physiol Biochem. 2013; 32: 1668–1680. doi: 10.1159/000356602 [DOI] [PubMed] [Google Scholar]
- 36.Guo R, Lin J, Xu W, Shen N, Mo L, Zhang C, et al. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells. Int J Mol Med. 2013; 31: 644–650. doi: 10.3892/ijmm.2013.1246 [DOI] [PubMed] [Google Scholar]
- 37.Ahmad A, Olah G, Szczesny B, Wood ME, Whiteman M, Szabo C AP39, A Mitochondrially Targeted Hydrogen Sulfide Donor, Exerts Protective Effects in Renal Epithelial Cells Subjected to Oxidative Stress in Vitro and in Acute Renal Injury in Vivo. Shock. 2016; 45: 88–97. doi: 10.1097/SHK.0000000000000478 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Wagner F, Scheuerle A, Weber S, Stahl B, McCook O, Knoferl MW, et al. Cardiopulmonary, histologic, and inflammatory effects of intravenous Na2S after blunt chest trauma-induced lung contusion in mice. J Trauma. 2011; 71: 1659–1667. doi: 10.1097/TA.0b013e318228842e [DOI] [PubMed] [Google Scholar]
- 39.Zuidema MY, Korthuis RJ Intravital microscopic methods to evaluate anti-inflammatory effects and signaling mechanisms evoked by hydrogen sulfide. Methods Enzymol. 2015; 555: 93–125. doi: 10.1016/bs.mie.2014.11.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Ning J, Mo L, Zhao H, Lu K, Lai X, Luo X, et al. Sodium Hydrosulphide alleviates remote lung injury following limb traumatic injury in rats. PLoS One. 2013; 8: e59100 doi: 10.1371/journal.pone.0059100 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All relevant data are within the paper and its Supporting Information files.